EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shin-ichi Takeda
Shinichiro Miyoshi
Yoshiki Sawa
Hikaru Matsuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohmori, K.
Right arrow Articles by Matsuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohmori, K.
Right arrow Articles by Matsuda, H.
Related Collections
Right arrow Lung - transplantation

Eur J Cardiothorac Surg 2005;27:23-27
© 2005 Elsevier Science NL


Attenuation of lung injury in allograft rejection using NF-{kappa}B decoy transfection—novel strategy for use in lung transplantation

Kenichi Ohmori*, Shin-ichi Takeda1, Shinichiro Miyoshi2, Masato Minami, Shigeru Nakane, Mitsunori Ohta, Yoshiki Sawa, Hikaru Matsuda

Department of Surgery (E1), Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita City, Osaka 565-0871, Japan

Received 20 June 2004; received in revised form 31 August 2004; accepted 3 September 2004.

* Corresponding author. Present Address: Department of General Thoracic Surgery, Kure Medical Center, Aoyamacho 1-3 Kure Hiroshima 737-0023, Japan. Tel.: +81 823 22 3111; fax: +81 823 21 0428. (E-mail: omorik{at}kure-nh.go.jp).

Objective: Increased production of nitric oxide (NO) is known to be a marker of lung allograft rejection and lung injury. NO production is up-regulated directly or indirectly by nuclear factor-kappa B (NF-{kappa}B), a transcriptional factor of inflammatory cytokines and iNOS. We attempted to determine whether transfection of an NF-{kappa}B decoy into allografts could reduce NO production and ameliorate acute lung injury during allograft rejection. Methods: Left lung transplantation was performed in pairs of Brown Norway (RT1n) and Lewis (RT1) rats. In Group NF (n=6), the allografts were flushed with 20ml of PBS solution containing a hemagglutinating virus of Japan (HVJ) liposome-ODN complex as an NF-{kappa}B decoy and preserved for 60min at 4°C. A scramble decoy was used in the positive control (Group S, n=5) and simple PBS solution in the negative control (Group C, n=5). Five days after transplantation without use of immuno-suppressants, exhaled NO, gas exchange, and graft histological rejection score were determined. Results: The exhaled NO level was significantly reduced in Group NF as compared with Group S (445±162 vs 1305±123 ppb, P<0.02), while improvements in PaO2 (197±28 vs. 60±18mmHg, P<0.02) and rejection score (1.8±0.3 vs. 2.5±0.4) were also observed. There were no differences in these parameters between Groups S and C. Conclusions: Inhibition of NF-{kappa}B activation in the allograft by ODN decoy transfection into the donor lung ameliorated lung injury during acute allograft rejection. Our results imply a possible therapeutic target for the inflammation process in lung transplantation clinical settings.

Key Words: Allograft lung injury • Gene Transfer • Lung transplantation • NF-{kappa}B




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. Holschermann, T. H.W. Stadlbauer, A. H. Wagner, H. Fingerhuth, H. Muth, S. Rong, F. Guler, H. Tillmanns, and M. Hecker
STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival
Cardiovasc Res, August 1, 2006; 71(3): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda
Application of HVJ-liposome mediated gene transfer in lung transplantation--distribution and transfection efficiency in the lung
Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 768 - 773.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.